Metacognitive reflection and insight therapy (MERIT) for patients with schizophrenia

Autor: Marieke E. Timmerman, André Aleman, M. aan het Rot, Paul H. Lysaker, Lex Wunderink, Johan Arends, Gerdina H. M. Pijnenborg, R. J. M. van Donkersgoed, S. de Jong, M. van der Gaag
Přispěvatelé: Clinical Psychology and Experimental Psychopathology, Psychometrics and Statistics, Perceptual and Cognitive Neuroscience (PCN), Interdisciplinary Centre Psychopathology and Emotion regulation (ICPE), Clinical Neuropsychology, Clinical Cognitive Neuropsychiatry Research Program (CCNP), Clinical Psychology, APH - Mental Health
Jazyk: angličtina
Rok vydání: 2019
Předmět:
Zdroj: Psychological Medicine, 49(2), 303-313. Cambridge University Press
de Jong, S, van Donkersgoed, R J M, Timmerman, ME, aan het Rot, M, Wunderink, L, Arends, J, van der Gaag, M, Aleman, A, Lysaker, P H & Pijnenborg, G H M 2019, ' Metacognitive reflection and insight therapy (MERIT) for patients with schizophrenia ', Psychological Medicine, vol. 49, no. 2, pp. 303-313 . https://doi.org/10.1017/S0033291718000855
ISSN: 1469-8978
0033-2917
Popis: BackgroundImpaired metacognition is associated with difficulties in the daily functioning of people with psychosis. Metacognition can be divided into four domains: Self-Reflection, Understanding the Other's Mind, Decentration, and Mastery. This study investigated whether Metacognitive Reflection and Insight Therapy (MERIT) can be used to improve metacognition.MethodsThis study is a randomized controlled trial. Patients in the active condition (n = 35) received forty MERIT sessions, the control group (n = 35) received treatment as usual. Multilevel intention-to-treat and completers analyses were performed for metacognition and secondary outcomes (psychotic symptomatology, cognitive insight, Theory of Mind, empathy, depression, self-stigma, quality of life, social functioning, and work readiness).ResultsEighteen out of 35 participants finished treatment, half the drop-out stemmed from therapist attrition (N = 5) or before the first session (N = 4). Intention-to-treat analysis demonstrated that in both groups metacognition improved between pre- and post-measurements, with no significant differences between the groups. Patients who received MERIT continued to improve, while the control group returned to baseline, leading to significant differences at follow-up. Completers analysis (18/35) showed improvements on the Metacognition Assessment Scale (MAS-A) scales Self Reflectivity and metacognitive Mastery at follow-up. No effects were found on secondary outcomes.ConclusionsOn average, participants in the MERIT group were, based on MAS-A scores, at follow-up more likely to recognize their thoughts as changeable rather than as facts. MERIT might be useful for patients whose self-reflection is too limited to benefit from other therapies. Given how no changes were found in secondary measures, further research is needed. Limitations and suggestions for future research are discussed.
Databáze: OpenAIRE